The Mental Health Liaison Group has asked CMS that the flexibilities around telehealth it enacted in response to the COVID-19 pandemic be extended one year after the emergency period is declared over to evaluate the potential for certain changes to become permanent.
It is ironic that deinstitutionalization from state psychiatric hospitals and decarceration from city and county jails—major objectives long sought by the behavioral health community—have turned into significant problems in the COVID-19 era.
Advocacy group Shatterproof says a pair of bills introduced in the House that would remove the separate waiver required for prescribing buprenorphine and set baseline requirements around preventing addiction and working with patients with OUD should be revisited in light of COVID-19.
Dave Aronberg, state attorney for the 15th judicial district in Florida, shared with Rx Summit attendees how his office has cracked down on patient brokering in Palm Beach County and helped individuals seeking treatment.
With much of the research in the Helping to End Addiction Long-term Initiative temporarily on pause, NIH Director Francis Collins, MD, PhD, and Nora Volkow, MD, director of the National Institute on Drug Abuse, shared with Rx Summit attendees other areas of progress for NIH.
Support for mental health services provided by telehealth continues to rise across the U.S., but obstacles to participation remain in several areas, per a recent report from the law firm Epstein Becker Green.